These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23824407)
1. The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus. Watson JT; Moawad FJ; Veerappan GR; Bassett JT; Maydonovitch CL; Horwhat JD; Wong RK Dig Dis Sci; 2013 Aug; 58(8):2253-60. PubMed ID: 23824407 [TBL] [Abstract][Full Text] [Related]
2. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Malesci A; Savarino V; Zentilin P; Belicchi M; Mela GS; Lapertosa G; Bocchia P; Ronchi G; Franceschi M Gastrointest Endosc; 1996 Dec; 44(6):700-5. PubMed ID: 8979061 [TBL] [Abstract][Full Text] [Related]
3. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy. Basu KK; Bale R; West KP; de Caestecker JS Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112 [TBL] [Abstract][Full Text] [Related]
4. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Ouatu-Lascar R; Triadafilopoulos G Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114 [TBL] [Abstract][Full Text] [Related]
5. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus. Loughney T; Maydonovitch CL; Wong RK Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018 [TBL] [Abstract][Full Text] [Related]
6. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546 [TBL] [Abstract][Full Text] [Related]
7. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599 [TBL] [Abstract][Full Text] [Related]
8. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Sharma P; Sampliner RE; Camargo E Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303 [TBL] [Abstract][Full Text] [Related]
9. Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility. Wetscher GJ; Profanter C; Gadenstätter M; Perdikis G; Glaser K; Hinder RA Langenbecks Arch Chir; 1997; 382(2):95-9. PubMed ID: 9128874 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537 [TBL] [Abstract][Full Text] [Related]
12. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. Pera M World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764 [TBL] [Abstract][Full Text] [Related]
13. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Fiorucci S; Santucci L; Farroni F; Pelli MA; Morelli A Am J Gastroenterol; 1989 Oct; 84(10):1263-7. PubMed ID: 2801676 [TBL] [Abstract][Full Text] [Related]
14. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302 [TBL] [Abstract][Full Text] [Related]
15. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease. Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553 [TBL] [Abstract][Full Text] [Related]
16. Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781 [TBL] [Abstract][Full Text] [Related]
17. Esophageal manometry findings and degree of acid exposure in short and long Barrett's esophagus. Helman L; Biccas BN; Lemme EM; Novais P; Fittipaldi V Arq Gastroenterol; 2012; 49(1):64-8. PubMed ID: 22481688 [TBL] [Abstract][Full Text] [Related]
18. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Sampliner RE; Faigel D; Fennerty MB; Lieberman D; Ippoliti A; Lewin K; Weinstein WM Gastrointest Endosc; 2001 May; 53(6):554-8. PubMed ID: 11323578 [TBL] [Abstract][Full Text] [Related]
20. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Glickman JN; Wang H; Das KM; Goyal RK; Spechler SJ; Antonioli D; Odze RD Am J Surg Pathol; 2001 Jan; 25(1):87-94. PubMed ID: 11145256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]